Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF)
about
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine ReceptorsStress triggers coronary mast cells leading to cardiac eventsEvaluation of nasal symptoms induced by platelet activating factor, after nasal challenge in both healthy and allergic rhinitis subjects pretreated with rupatadine, levocetirizine or placebo in a cross-over study design.Rupatadine does not potentiate the CNS depressant effects of lorazepam: randomized, double-blind, crossover, repeated dose, placebo-controlled study.A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?Inhibitory effect of topical adelmidrol on antigen-induced skin wheal and mast cell behavior in a canine model of allergic dermatitisMorning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial.Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient miceOlopatadine hydrochloride and rupatadine fumarate in seasonal allergic rhinitis: A comparative study of efficacy and safety.Rupatadine in Established Treatment Schemes Improves Chronic Spontaneous Urticaria Symptoms and Patients' Quality of Life: a Prospective, Non-interventional Trial.Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor.A direct comparison of efficacy between desloratadine and rupatadine in seasonal allergic rhinoconjunctivitis: a randomized, double-blind, placebo-controlled studyRupatadine: efficacy and safety of a non-sedating antihistamine with PAF-antagonist effects.Novel targets and regulatory ordeal by QT interval.Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice.Development of a Stability-Indicating RP-HPLC Method for the Determination of Rupatadine and its Degradation Products in Solid Oral Dosage Form.Herbex-kid Inhibits Immediate Hypersensitivity Reactions in Mice and Rats.Rupatadine.Effects of rupatadine, a new dual antagonist of histamine and platelet-activating factor receptors, on human cardiac kv1.5 channels.Rupatadine: pharmacological profile and its use in the treatment of allergic rhinitis.Comparative efficacy of non-sedating antihistamine updosing in patients with chronic urticaria.A preliminary study on efficacy of rupatadine for the treatment of acute dengue infection.
P2860
Q26827568-8E25C46A-25D3-43D7-A87B-6E068292CAC7Q27022598-B858521C-F273-41C5-8E9D-134803D37617Q30438074-A9CF42A8-1DCF-4D08-92EE-D1D9CCB73533Q30475256-53A00B3C-24F7-4F95-88CE-CFF359C1D1A2Q33552144-7A8128B2-326C-4E2F-8061-6E591A05BB6FQ34488693-CD3E893E-ED5C-44DA-BF7A-246012E2ECEAQ35050198-DF3F7CF2-E732-40D9-816C-ADC52E441972Q35088319-31BD135F-9C10-4BAD-9542-3111EC8DFAC5Q35411434-7D52632E-D56E-40F1-8D67-EB895D24D93DQ36359983-EEC035A9-8FB7-4DB8-BB24-7CC2E31AB762Q36400935-5F38670E-D9DA-4E85-8E39-037238D07457Q36638677-05BFEE30-957E-4BB8-BD0A-8BF076B3F8C3Q38539741-4D9965E6-E15F-4522-BEE3-E37F86A50480Q39871284-C4333EF9-905E-4AB1-8077-6CF65EF20866Q41298937-53BE88E4-042B-4BE5-880B-D6982E92465CQ41940959-848BBC2C-001E-4267-A81A-61F11B5869EEQ41973097-3E65A810-55C2-414C-9B10-109DB7CA0622Q42120249-49B41F71-E81A-4E8B-A873-1561CAA2460CQ42198666-2C76B299-A729-468A-A712-ACB470A450C9Q42327009-4925C38E-2013-4685-AE6E-AA6BD4AE9827Q43190363-CC89E01D-CDDE-47B9-BB63-A0985F30BA23Q51745540-E4C93FA6-0F83-4F6F-8586-59DD0089D7C3
P2860
Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF)
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Rupatadine, a new potent, oral ...... atelet-activating factor (PAF)
@ast
Rupatadine, a new potent, oral ...... atelet-activating factor (PAF)
@en
Rupatadine, a new potent, oral ...... atelet-activating factor (PAF)
@nl
type
label
Rupatadine, a new potent, oral ...... atelet-activating factor (PAF)
@ast
Rupatadine, a new potent, oral ...... atelet-activating factor (PAF)
@en
Rupatadine, a new potent, oral ...... atelet-activating factor (PAF)
@nl
prefLabel
Rupatadine, a new potent, oral ...... atelet-activating factor (PAF)
@ast
Rupatadine, a new potent, oral ...... atelet-activating factor (PAF)
@en
Rupatadine, a new potent, oral ...... atelet-activating factor (PAF)
@nl
P2093
P1476
Rupatadine, a new potent, oral ...... atelet-activating factor (PAF)
@en
P2093
A Puigdemont
J García-Rafanell
R Ferrando
P304
P407
P577
1997-01-01T00:00:00Z